Clinical staging according to AJCC (8th edition) ---------------------------------------------------------------------------------------------------Patients Pathology Sex Age (years) T stage N stage M stage  TNM stage  SI of IHC   1  ESCC  Male  65  T3  N0  M0  II  1  ANTT  1  2  ESCC  Male  56  T3  N1  M0  III  0  ANTT  0  3  ESCC  Male  60  T3  N1  M0  III  2  ANTT  2  4  ESCC  Male  64  T3  N0  M0  II  8  ANTT  1  5  ESCC  Male  59  T3  N0  M0  II  1  ANTT  0  6  ESCC  Male  57  T2  N1  M0  II  6  ANTT  2  7  ESCC  Female  58  T3  N1  M0  III  3  ANTT  2  8  ESCC  Male  70  T3  N0  M0  II  4  ANTT  3  9  ESCC  Female  74  T3  N1  M0  III  3  ANTT  1  10  ESCC  Male  66  T3  N0  M0  II  12  ANTT  1  11  ESCC  Female  52  T3  N1  M0  III  8  ANTT  2  12  ESCC  Male  75  T3  N0  M0  II  1  ANTT  1  13  ESCC  Male  51  T3  N0  M0  II  0  ANTT  1  14  ESCC  Male  51  T3  N2  M0  II  4  ANTT  1  15  ESCC  Male  59  T3  N2  M0  II  8  ANTT  2  16  ESCC  Female  73  T3  N0  M0  II  12  ANTT  4  17  ESCC  Male  63  T3  N1  M0  III  3  ANTT  1  18  ESCC  Male  51  T3  N2  M0  III  3  ANTT  1  19  ESCC  Male  60  T3  N2  M0  III  1  ANTT  0  20  ESCC  Female  50  T3  N0  M0  II  4  ANTT  3  21  ESCC  Male  71  T3  N2  M0  III  3  ANTT  0  22  ESCC  Male  51  T2  N1  M0  II  2  ANTT  0  23  ESCC  Male  64  T4b  N3  M0  IVa  2  ANTT  2  24  ESCC  Male  64  T3  N0  M0  II  1  ANTT  1  25  ESCC  Male  55  T2  N1  M0  II  2  ANTT  1  26  ESCC  Male  52  T3  N1  M0  III  2  ANTT  1  27  ESCC  Male  59  T3  N3 M0 IVa 1 ANTT 0 Clinical staging according to AJCC (8th edition) TNM stage  SI of IHC   28  ESCC  Male  70  T3  N1  M0  III  1  ANTT  0  29  ESCC  Male  65  T3  N0  M0  II  4  ANTT  2  30  ESCC  Male  63  T2  N1  M0  II  3  ANTT  1  31  ESCC  Female  67  T3  N0  M0  II  8  ANTT  1  32  ESCC  Male  48  T3  N1  M0  III  3  ANTT  1  33  ESCC  Male  53  T3  N1  M0  III  1  ANTT  0  34  ESCC  Male  69  T3  N1  M0  III  2  ANTT  1  35  ESCC  Male  61  T3  N1  M0  III  3  ANTT  1  36  ESCC  Male  77  T3  N0  M0  II  4  ANTT  2  37  ESCC  Male  61  T3  N1  M0  III  8  ANTT  2  38  ESCC  Male  59  T3  N0  M0  II  0  ANTT  1  39  ESCC  Female  56  T4b  N0  M0  IVa  0  ANTT  0  40  ESCC  Female  68  T3  N0  M0  II  2  ANTT  1  41  ESCC  Male  77  T3  N0  M0  II  3  ANTT  0  42  ESCC  Male  57  T2  N1  M0  II  4  ANTT  1  43  ESCC  Male  61  T3  N0  M0  II  2  ANTT  1  44  ESCC  Male  68  T3  N3  M0  IVa  4  ANTT  2  45  ESCC  Female  72  T3  N0  M0  II  3  ANTT  1  46  ESCC  Male  57  T3  N0  M0  II  3  ANTT  0  47  ESCC  Male  74  T3  N0  M0  II  8  ANTT  2  48  ESCC  Male  72  T2  N2  M0  III  8  ANTT  2  49  ESCC  Female  65  T3  N0  M0  II  4  ANTT  2  50  ESCC  Male  75  T3  N0  M0  II  2  ANTT  1  51  ESCC  Female  63  T3  N0  M0  II  3  ANTT  1  52  ESCC  Female  73  T3  N2  M0  III  4  ANTT  1  53  ESCC  Male  76  T3  N0  M0  II  2  ANTT  0  54  ESCC  Male  61  T3  N1  M0  III  8  ANTT  2   Table SI . Continued. TNM stage  SI of IHC   55  ESCC  Male  79  T2  N3  M0  IVa  3  ANTT  1  56  ESCC  Male  72  T3  N1  M0  III  8  ANTT  2  57  ESCC  Male  54  T3  N1  M0  III  3  ANTT  1  58  ESCC  Male  76  T2  N1  M0  II  1  ANTT  1  59  ESCC  Male  65  T3  N3  M0  IVa  8  ANTT  1  60  ESCC  Female  68  T3  N1  M0  III  4  ANTT  2  61  ESCC  Male  81  T3  N1  M0  III  2  ANTT  1  62  ESCC  Male  64  T3  N1  M0  III  1  ANTT  2  63  ESCC  Female  71  T1b  N1  M0  I  1  ANTT  1  64  ESCC  Male  48  T3  N2  M0  III  8  ANTT  3  65  ESCC  Male  76  T1b  N1  M0  I  4  ANTT  1  66  ESCC  Male  52  T2  N1  M0  II  4  ANTT  1  67  ESCC  Female  68  T3  N1  M0  III  4  ANTT  1  68  ESCC  Female  74  T1b  N1  M0  I  8  ANTT  1  69  ESCC  Male  63  T1a  N1  M0  I  4  ANTT  0  70  ESCC  Male  52  T3  N1  M0  III  2  ANTT  1 ESCC, esophageal squamous cell carcinoma; ANTT, adjacent non-tumor tissues; SI, scoring index; IHC, immunohistochemistry; AJCC, American Joint Committee on Cancer. Clinical staging according to AJCC (8th edition) Male  73  T3  N1  M0  III  3  2  ESCC  Male  73  T3  N0  M0  II  1  3  ESCC  Female  56  T3  N0  M0  II  3  4  ESCC  Female  71  T3  N0  M0  II  3  5  ESCC  Female  81  T2  N0  M0  II  0  6  ESCC  Female  67  T3  N2  M0  III  8  7  ESCC  Male  72  T3  N0  M0  II  2  8  ESCC  Male  69  T3  N1  M0  III  3  9  ESCC  Male  72  T3  N2  M0  III  1  10  ESCC  Male  74  T3  N2  M0  III  4  11  ESCC  Male  73  T3  N0  M0  II  3  12  ESCC  Male  51  T3  N0  M0  II  8  13  ESCC  Male  49  T3  N2  M0  III  3  14  ESCC  Female  82  T3  N2  M0  III  8  15  ESCC  Male  65  T3  N1  M0  III  4  16  ESCC  Male  80  T3  N1  M0  III  4  17  ESCC  Female  79  T3  N0  M0  II  6  18  ESCC  Male  50  T3  N2  M0  III  4  19  ESCC  Male  54  T4b  N2  M0  IVa  8  20  ESCC  Female  74  T3  N0  M0  II  12  21  ESCC  Male  62  T3  N2  M0  III  8  22  ESCC  Female  74  T3  N0  M0  II  8  23  ESCC  Male  74  T3  N2  M0  III  3  24  ESCC  Male  79  T3  N1  M0  III  12  25  ESCC  Male  65  T3  N1  M0  III  2 ESCC, esophageal squamous cell carcinoma; ANTT, adjacent non-tumor tissues; SI, scoring index; IHC, immunohistochemistry; AJCC, American Joint Committee on Cancer.
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